Activity of Monoamine Oxidase in the Nigrostriatal System at Presymptomatic and Early Symptomatic Stages of Parkinsonism in Mice
Gespeichert in:
Verfasser / Beitragende:
[G. Khakimova, E. Kozina, O. Buneeva, L. Aksenova, A. Medvedev, M. Ugryumov]
Ort, Verlag, Jahr:
2015
Enthalten in:
Bulletin of Experimental Biology and Medicine, 159/4(2015-08-01), 456-458
Format:
Artikel (online)
Online Zugang:
| LEADER | caa a22 4500 | ||
|---|---|---|---|
| 001 | 605535752 | ||
| 003 | CHVBK | ||
| 005 | 20210128100849.0 | ||
| 007 | cr unu---uuuuu | ||
| 008 | 210128e20150801xx s 000 0 eng | ||
| 024 | 7 | 0 | |a 10.1007/s10517-015-2990-x |2 doi |
| 035 | |a (NATIONALLICENCE)springer-10.1007/s10517-015-2990-x | ||
| 245 | 0 | 0 | |a Activity of Monoamine Oxidase in the Nigrostriatal System at Presymptomatic and Early Symptomatic Stages of Parkinsonism in Mice |h [Elektronische Daten] |c [G. Khakimova, E. Kozina, O. Buneeva, L. Aksenova, A. Medvedev, M. Ugryumov] |
| 520 | 3 | |a Activities of monoamine oxidases A and B were examined on the models of presymptomatic and early symptomatic stages of Parkinson's disease developed in mice treated with MPTP, a specific neurotoxin affecting dopaminergic neurons. Activity of monoamine oxidases A, the key enzyme of dopamine degradation, is increased in neuronal somas during the symptomatic stage, and it is augmented in the axons during both stages. Neuronal activity of monoamine oxidases A is higher during the symptomatic stage than that during the presymptomatic stage, which can explain depletion of intercellular dopamine and appearance of motor disturbances. Activity of monoamine oxidase B in the striatum is reduced during the presymptomatic stage, but returns to the control level during the symptomatic stage. Variation in monoamine oxidase activity seems to reflect the compensatory mechanisms triggered in degrading nigrostriatal dopaminergic system. | |
| 540 | |a Springer Science+Business Media New York, 2015 | ||
| 690 | 7 | |a monoamine oxidase |2 nationallicence | |
| 690 | 7 | |a dopamine |2 nationallicence | |
| 690 | 7 | |a mice |2 nationallicence | |
| 690 | 7 | |a MPTP , Parkinson's disease |2 nationallicence | |
| 700 | 1 | |a Khakimova |D G. |u N. K. Koltsov Institute of Developmental Biology, Russian Academy of Sciences, Moscow, Russia |4 aut | |
| 700 | 1 | |a Kozina |D E. |u N. K. Koltsov Institute of Developmental Biology, Russian Academy of Sciences, Moscow, Russia |4 aut | |
| 700 | 1 | |a Buneeva |D O. |u V. N. Orekhovich Institute of Biomedical Chemistry, Russian Academy of Medical Sciences, Moscow, Russia |4 aut | |
| 700 | 1 | |a Aksenova |D L. |u V. N. Orekhovich Institute of Biomedical Chemistry, Russian Academy of Medical Sciences, Moscow, Russia |4 aut | |
| 700 | 1 | |a Medvedev |D A. |u V. N. Orekhovich Institute of Biomedical Chemistry, Russian Academy of Medical Sciences, Moscow, Russia |4 aut | |
| 700 | 1 | |a Ugryumov |D M. |u N. K. Koltsov Institute of Developmental Biology, Russian Academy of Sciences, Moscow, Russia |4 aut | |
| 773 | 0 | |t Bulletin of Experimental Biology and Medicine |d Springer US; http://www.springer-ny.com |g 159/4(2015-08-01), 456-458 |x 0007-4888 |q 159:4<456 |1 2015 |2 159 |o 10517 | |
| 856 | 4 | 0 | |u https://doi.org/10.1007/s10517-015-2990-x |q text/html |z Onlinezugriff via DOI |
| 898 | |a BK010053 |b XK010053 |c XK010000 | ||
| 900 | 7 | |a Metadata rights reserved |b Springer special CC-BY-NC licence |2 nationallicence | |
| 908 | |D 1 |a research-article |2 jats | ||
| 949 | |B NATIONALLICENCE |F NATIONALLICENCE |b NL-springer | ||
| 950 | |B NATIONALLICENCE |P 856 |E 40 |u https://doi.org/10.1007/s10517-015-2990-x |q text/html |z Onlinezugriff via DOI | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Khakimova |D G. |u N. K. Koltsov Institute of Developmental Biology, Russian Academy of Sciences, Moscow, Russia |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Kozina |D E. |u N. K. Koltsov Institute of Developmental Biology, Russian Academy of Sciences, Moscow, Russia |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Buneeva |D O. |u V. N. Orekhovich Institute of Biomedical Chemistry, Russian Academy of Medical Sciences, Moscow, Russia |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Aksenova |D L. |u V. N. Orekhovich Institute of Biomedical Chemistry, Russian Academy of Medical Sciences, Moscow, Russia |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Medvedev |D A. |u V. N. Orekhovich Institute of Biomedical Chemistry, Russian Academy of Medical Sciences, Moscow, Russia |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Ugryumov |D M. |u N. K. Koltsov Institute of Developmental Biology, Russian Academy of Sciences, Moscow, Russia |4 aut | ||
| 950 | |B NATIONALLICENCE |P 773 |E 0- |t Bulletin of Experimental Biology and Medicine |d Springer US; http://www.springer-ny.com |g 159/4(2015-08-01), 456-458 |x 0007-4888 |q 159:4<456 |1 2015 |2 159 |o 10517 | ||